Paper Details

  1. Home
  2. Paper Details

Clinical safety and tolerance of azithromycin in children.

Author: HopkinsS

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This study reviewed safety data from several clinical trials comparing azithromycin to other antibiotics in children. The review found that azithromycin was associated with significantly fewer side effects than other antibiotics, particularly gastrointestinal side effects. This suggests that azithromycin is a safe and well-tolerated antibiotic option for treating infections in children.
Paper Details　
Original Abstract of the Article :
An analysis of the safety data emanating from several clinical trials of the use of azithromycin in children has been undertaken. The studies compared azithromycin with standard regimens of various comparator agents: co-amoxiclav, amoxycillin, penicillin V, erythromycin, dicloxacillin and flucloxaci...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/jac/31.suppl_e.111

データ提供：米国国立医学図書館（NLM）

Azithromycin in Children: A Safe and Effective Treatment Option

This study delves into the world of antibiotics, focusing on the safety and efficacy of azithromycin in children. The study analyzed data from several clinical trials, comparing azithromycin to standard regimens of other antibiotics in the treatment of various childhood infections. It's like venturing into the desert of medical research, seeking to uncover the most effective and safest treatment options for young patients.

Azithromycin: A Promising Alternative for Childhood Infections

The study revealed that azithromycin was generally well-tolerated by children, with fewer reported side effects compared to other antibiotics. It's like discovering a new path across the desert, offering a smoother and safer journey for young travelers. The study found that the most common side effects were gastrointestinal, but these were less frequent in children treated with azithromycin.

Safety and Efficacy: A Guiding Principle in Pediatric Care

This study underscores the importance of carefully considering the safety and efficacy of medications in pediatric care. It's like choosing the right tools for navigating a challenging desert environment, ensuring the safety and well-being of young explorers. The study provides valuable information for healthcare professionals, guiding their treatment decisions and ensuring the best possible outcomes for children.

Dr.Camel's Conclusion

This research adds valuable knowledge to the vast desert of medical research, highlighting the safety and efficacy of azithromycin in treating childhood infections. It's a testament to the ongoing quest for better and safer treatment options for children, ensuring that their health journey is as smooth and comfortable as possible. It's a reminder that even in the unpredictable landscape of medicine, there are always new discoveries and advancements, leading to a brighter future for our youngest patients.

Date :
  1. Date Completed 1993-10-05
  2. Date Revised 2019-05-12
Further Info :

Pubmed ID

8396082

DOI: Digital Object Identifier

10.1093/jac/31.suppl_e.111

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.